Outcomes of patients with Richter transformation who received no prior chemoimmunotherapy for their CLL.
Saved in:
| Title: | Outcomes of patients with Richter transformation who received no prior chemoimmunotherapy for their CLL. |
|---|---|
| Authors: | Kittai AS; Icahn School of Medicine at Mount Sinai, New York, NY, USA. Adam.kittai@mssm.edu., Huang Y; Division of Hematology, The Ohio State University, Columbus, OH, USA., Miller S; Division of Hematology, The Ohio State University, Columbus, OH, USA., Allan JN; Weill Cornell Medicine, New York, NY, USA., Bhat SA; Division of Hematology, The Ohio State University, Columbus, OH, USA., Bond DA; Division of Hematology, The Ohio State University, Columbus, OH, USA., Brander DM; Division of Hematologic Malignancies and Cellular Therapy, Duke University, Duke Cancer Institute, Durham, NC, USA., Byrd JC; Department of Internal Medicine, University of Cincinnati, Cincinnati, OH, USA., Chavez JC; Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL, USA., Chong E; University of Pennsylvania Abramson Cancer Center, Philadelphia, PA, USA., Davids MS; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Danilov AV; City of Hope National Medical Center, Duarte, CA, USA., Ding W; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Dowling MR; Department of Clinical Haematology, Royal Melbourne Hospital and Peter MacCallum Cancer Centre, Melbourne, Australia.; The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia., Dvorak-Kornaus K; Division of Hematology, The Ohio State University, Columbus, OH, USA., Freedman H; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Hampel PJ; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Ho C; Division of Medical Oncology, University of Washington, Seattle, WA, USA., Hwang SR; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Islam P; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Malakhov N; Weill Cornell Medicine, New York, NY, USA., Matasar M; Division of Blood Disorders, Rutgers Cancer Institute, New Brunswick, NJ, USA., Miller C; Division of Pathology, The Ohio State University, Columbus, OH, USA., Omer Z; Department of Internal Medicine, University of Cincinnati, Cincinnati, OH, USA., Parikh SA; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Parry E; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Rabe KG; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA., Raess PW; Department of Pathology and Laboratory Medicine, Oregon Health & Science University, Portland, OR, USA., Rai M; Center for Hematologic Malignancies, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA., Roeker L; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Rhodes J; Division of Blood Disorders, Rutgers Cancer Institute, New Brunswick, NJ, USA., Rogers KA; Division of Hematology, The Ohio State University, Columbus, OH, USA., Saha A; Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL, USA., Schade J; Division of Blood Disorders, Rutgers Cancer Institute, New Brunswick, NJ, USA., Scott HW; Department of Clinical Haematology, Royal Melbourne Hospital and Peter MacCallum Cancer Centre, Melbourne, Australia., Shadman M; Division of Medical Oncology, University of Washington, Seattle, WA, USA., Shouse G; City of Hope National Medical Center, Duarte, CA, USA., Skarbnik A; Novant Health Cancer Institute, Lymphoma and CLL/SLL Program, Charlotte, NC, USA., Spurgeon S; Center for Hematologic Malignancies, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA., Stephens DM; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA., Thompson MC; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Thompson PA; Department of Clinical Haematology, Royal Melbourne Hospital and Peter MacCallum Cancer Centre, Melbourne, Australia.; The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia., Wang Y; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Yano M; The Ohio State University College of Medicine, Columbus, OH, USA., Woyach JA; Division of Hematology, The Ohio State University, Columbus, OH, USA. |
| Source: | Blood cancer journal [Blood Cancer J] 2025 Feb 20; Vol. 15 (1), pp. 23. Date of Electronic Publication: 2025 Feb 20. |
| Publication Type: | Letter |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2044-5385 |
|---|---|
| DOI: | 10.1038/s41408-025-01236-6 |
